Telangana has inaugurated a new integrated oncology manufacturing facility of Ciro Pharma at Biotech Park Phase III in Karakapatla, Siddipet, to strengthen its life sciences and pharmaceutical manufacturing ecosystem.
Established with an investment of ₹800 crore ($84 million), the facility will manufacture advanced oncology medicines, including oral formulations, sterile injectables, lyophilised powder injections, and soft gel capsules. The project is expected to generate around 500 direct employment opportunities while enhancing Telangana's manufacturing capabilities in high-value pharmaceutical products.
The inauguration aligns with Telangana's broader strategy to position itself as a leading destination for pharmaceutical manufacturing, biotechnology research, AI-enabled healthcare innovation, and sustainable pharmaceutical production. The government has been actively promoting investments across the life sciences sector to drive economic growth while creating skilled employment opportunities.
The new facility is expected to bolster the state's position as a global hub for life sciences, particularly in the manufacturing of specialised cancer therapies that cater to both domestic and international markets.
Speaking at the inauguration, Sridhar Babu Duddilla, Minister of Information Technology, Electronics, Communications, Industries & Legislative Affairs in the Telangana government, reiterated the state government’s commitment to building a globally competitive life sciences ecosystem by attracting high-value investments and expanding advanced manufacturing capabilities.
"Our government is committed to making Telangana a global life sciences innovation hub by promoting world-class manufacturing, research, AI-driven healthcare, sustainable green pharma, and high-value investments that generate quality employment and drive inclusive economic growth," he mentioned on X.
Your reaction
Discussion
What's your take on this story?
No comments yet — be the first to share your view.